Amsterdam Institute for Molecules, Medicines and Systems (AIMMS)

The last decade has witnessed major breakthroughs in the fields of molecular, cellular and systems biology, and also in related enabling technologies. These innovations fuel a general excitement that a molecular up to systems understanding of health and disease is within reach.

These developments have lead to establishment of the Amsterdam Institute for Molecules, Medicines and Systems (AIMMS) at 1 April 2010. In AIMMS, 17 of the best research groups in pharmaceutical sciences, life sciences, computational life sciences and molecular sciences at VU Amsterdam have joined forces. By integrating these scientific disciplines, AIMMS is aiming at the elucidation of molecular mechanisms of diseases and the development of novel and safer drugs, therapeutics (e.g. proteins, antibodies and other biologics) and diagnostics (e.g. molecular and translational biomarkers).

AIMMS website